Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Cellectar’s CLR 131 Receives FDA Orphan Drug Designation for Treatment of Ewing’s Sarcoma

firstwordpharmaJuly 10, 2018

Tag: Press Release , CLR 131 , Cellectar

PharmaSources Customer Service